Aimee Campbell

Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment

Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse

The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

Model and approach for assessing implementation context and fidelity in the HEALing Communities Study

Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study

Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone

Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial

How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies

Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis

Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic”

Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial